B. Metzler Seel. Sohn & Co. Ag Dr Reddys Laboratories LTD Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $9.07 Billion
- Q1 2024
A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 29,846 shares of RDY stock, worth $2.27 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
29,846
Previous 33,096
9.82%
Holding current value
$2.27 Million
Previous $2.3 Million
4.91%
% of portfolio
0.02%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding RDY
# of Institutions
242Shares Held
23.6MCall Options Held
25.2KPut Options Held
8.5K-
Black Rock Inc. New York, NY2.18MShares$166 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A62.16MShares$165 Million0.04% of portfolio
-
Robeco Institutional Asset Management B.V.1.97MShares$150 Million0.32% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.93MShares$147 Million0.22% of portfolio
-
Goldman Sachs Group Inc New York, NY1.56MShares$119 Million0.02% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $12.6B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...